Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics

Journal of Proteomics

Volumn 113, Issue , 2015, Pages 388-399

  Ronsein, Graziella E ^a   Pamir, Nathalie ^a   von Haller, Priska D ^a   Kim, Daniel S ^a   Oda, Michael N ^b   Jarvik, Gail P ^a   Vaisar, Tomas ^a   Heinecke, Jay W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

HDL; PRM; Single internal standard protein; SRM; Targeted proteomics

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; NITROGEN 15; NITROGEN;

ACCURACY; AMINO ACID SEQUENCE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DYNAMICS; HUMAN; ION MONITORING; ISOTOPE LABELING; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; NONLINEAR SYSTEM; NORMAL HUMAN; PARALLEL REACTION MONITORING; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SELECTED REACTION MONITORING; SEQUENCE ANALYSIS; BLOOD; CHEMISTRY; CLINICAL TRIAL; FEMALE; MALE; MULTICENTER STUDY; PHYSIOLOGIC MONITORING; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

APOLIPOPROTEIN A-I; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MONITORING, PHYSIOLOGIC; NITROGEN ISOTOPES; PROTEOMICS;

EID: 84909953587     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.10.017     Document Type: Article

References (36)

1. Jaffe J.D., Keshishian H., Chang B., Addona T.A., Gillette M.A., Carr S.A. Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification. Mol Cell Proteomics 2008, 7:1952-1962.
2. Smith R.D. Mass spectrometry in biomarker applications: from untargeted discovery to targeted verification, and implications for platform convergence and clinical application. Clin Chem 2012, 58:528-530.
3. Lange V., Picotti P., Domon B., Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008, 4:1-14.
4. Gallien S., Duriez E., Demeure K., Domon B. Selectivity of LC-MS/MS analysis: implication for proteomics experiments. J Proteomics 2013, 81:148-158.
5. Addona T.A., Abbatiello S.E., Schilling B., Skates S.J., Mani D.R., Bunk D.M., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009, 27:633-641.
6. Brun V., Dupuis A., Adrait A., Marcellin M., Thomas D., Court M., et al. Isotope-labeled protein standards: toward absolute quantitative proteomics. Mol Cell Proteomics 2007, 6:2139-2149.
7. Hoofnagle A.N., Becker J.O., Oda M.N., Cavigiolio G., Mayer P., Vaisar T. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin Chem 2012, 58:777-781.
8. Gallien S., Bourmaud A., Kim S.Y., Domon B. Technical considerations for large-scale parallel reaction monitoring analysis. J Proteomics 2013, 4:544-547.
9. Law K.P., Lim Y.P. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring. Expert Rev Proteomics 2013, 10:551-566.
10. Peterson A.C., Russell J.D., Bailey D.J., Westphall M.S., Coon J.J. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics 2012, 11:1475-1488.
11. Schiffmann C., Hansen R., Baumann S., Kublik A., Nielsen P.H., Adrian L., et al. Comparison of targeted peptide quantification assays for reductive dehalogenases by selective reaction monitoring (SRM) and precursor reaction monitoring (PRM). Anal Bioanal Chem 2014, 406:283-291.
12. Gallien S., Duriez E., Crone C., Kellmann M., Moehring T., Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 2012, 11:1709-1723.
13. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34:1345-1353.
14. Davidson W.S., Silva R.A., Chantepie S., Lagor W.R., Chapman M.J., Kontush A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol 2009, 29:870-876.
15. Shah A.S., Tan L., Long J.L., Davidson W.S. Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J Lipid Res 2013, 54:2575-2585.
16. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
17. Khera A.V., Cuchel M., de la Llera-Moya M., Rodrigues A., Burke M.F., Jafri K., et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011, 364:127-135.
18. Rader D.J., Tall A.R. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?. Nat Med 2012, 18:1344-1346.
19. Schwartz G.G., Olsson A.G., Abt M., Ballantyne C.M., Barter P.J., Brumm J., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012, 367:2089-2099.
20. Gillette M.A., Carr S.A. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods 2013, 10:28-34.
21. Picotti P., Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012, 9:555-566.
22. Picotti P., Rinner O., Stallmach R., Dautel F., Farrah T., Domon B., et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010, 7:43-46.
23. Mohammed Y., Domański D., Jackson A.M., Smith D.S., Deelder A.M., Palmblad M., et al. PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. J Proteomics 2014, 106:151-161.
24. Ryan R.O., Forte T.M., Oda M.N. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr Purif 2003, 27:98-103.
25. Jarvik G.P., Hatsukami T.S., Carlson C., Richter R.J., Jampsa R., Brophy V.H., et al. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol 2003, 23:1465-1471.
26. Mendez A., Oram J., Bierman E. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 1991, 266:10104-10111.
27. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheung M.C., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007, 117:746-756.
28. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
29. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
30. MacLean B., Tomazela D.M., Shulman N., Chambers M., Finney G.L., Frewen B., et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26:966-968.
31. Almeida A.M., Castel-Branco M.M., Falcão A.C. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J Chromatogr B 2002, 774:215-222.
32. Keshishian H., Addona T., Burgess M., Kuhn E., Carr S.A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007, 6:2212-2229.
33. Domon B. Considerations on selected reaction monitoring experiments: Implications for the selectivity and accuracy of measurements. Proteomics Clin Appl 2012, 6:609-614.
34. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
35. Alwaili K., Bailey D., Awan Z., Bailey S.D., Ruel I., Hafiane A., et al. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta 2012, 3:405-415.
36. Yassine H.N., Jackson A.M., Borges C.R., Billheimer D., Koh H., Smith D., et al. The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins. Lipids Health Dis 2014, 13:13-18.